title: Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis.
abstract: Candida albicans is a commensal organism that can be isolated from the majority of healthy individuals. However, in certain susceptible individuals C. albicans can become pathogenic leading to the mucocutaneous infection; oral candidiasis. Murine models and in vitro monolayer cultures have generated some data on the likely virulence and host factors that contribute to oral candidiasis but these models have limitations. Recently, tissue engineered oral mucosal models have been developed to mimic the normal oral mucosa but little information is available on their true representation. In this study, we assessed the histological features of three different tissue engineered oral mucosal models compared to the normal oral mucosa and analysed both cell damage and cytokine release following infection with C. albicans. Models comprised of normal oral keratinocytes and a fibroblast-containing matrix displayed more similar immunohistological and proliferation characteristics to normal mucosa, compared to models composed of an oral carcinoma cell line. Although all models were invaded and damaged by C. albicans in a similar manner, the cytokine response was much more pronounced in models containing normal keratinocytes. These data suggest that models based on normal keratinocytes atop a fibroblast-containing connective tissue will significantly aid in dissecting the molecular pathogenesis of oral candidiasis.
authors.affiliation: Academic Unit of Oral & Maxillofacial Medicine & Surgery, School of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK.
authors.forename: Nishant P
authors.initials: NP
authors.lastname: Yadev
authors.forename: Craig
authors.initials: C
authors.lastname: Murdoch
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Saville
authors.forename: Martin H
authors.initials: MH
authors.lastname: Thornhill
mesh_terms: D000818:Animals; D002176:Candida albicans / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D002180:Candidiasis, Oral / Q000276:immunology / Q000378:metabolism / Q000382:microbiology* / Q000473:pathology*; D016923:Cell Death / Q000502:physiology; D016207:Cytokines / Q000096:biosynthesis; D005347:Fibroblasts / Q000166:cytology / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D015603:Keratinocytes / Q000166:cytology / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D051379:Mice; D009061:Mouth Mucosa / Q000166:cytology* / Q000276:immunology / Q000378:metabolism / Q000382:microbiology* / Q000473:pathology; D023822:Tissue Engineering / Q000379:methods*; D015854:Up-Regulation; D014774:Virulence / Q000502:physiology; D023083:beta-Defensins / Q000096:biosynthesis / Q000235:genetics
chemical_list: D016207:Cytokines; C106641:DEFB4A protein, human; D023083:beta-Defensins